Felvizumab

Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus.[1][2]

Felvizumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from mouse)
TargetRSV
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
 NY (what is this?)  (verify)

References
  1. "WHO Drug Information" (PDF). Archived from the original (PDF) on February 23, 2012.
  2. Milne GW (2018). "6591: Felvizumab". Drugs synonyms and properties. London: Routledge Revivals. ISBN 978-1-351-78989-9.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.